Medtronic (NYSE: MDT) reported Q4 EPS of $1.27, $0.01 better than the analyst estimate of $1.26. Revenue for the quarter came in at $7.57 billion versus the consensus estimate of $7.49 billion.

GUIDANCE:

Medtronic sees FY2017 EPS of $4.60-$4.70, versus the consensus of $4.70.

In fiscal year 2017, given current trends, the company expects constant currency revenue growth to be in the upper-half of the mid-single digit range, which is in the range of 5 to 6 percent and excludes the estimated negative 150 basis point impact from the extra selling week the company had in the first quarter of fiscal year 2016. The company expects a negative impact from foreign currency in fiscal year 2017 of approximately $25 to $75 million based on current exchange rates.

For earnings history and earnings-related data on Medtronic (MDT) click here.

Earnings Guidance

Wedbush Raises Price Target on Medtronic (MDT) to $82 Following 4Q Report June 1, 2016 8:41 AM Leerink Partners Raises Price Target on Medtronic (MDT) Following 4Q Report June 1, 2016 7:49 AM BTIG Downgrades Medtronic, Inc. (MDT) to NeutralJune 1, 2016 7:18 AM Medtronic (MDT): In-Line Quarter, Raising PT - Piper JaffrayJune 1, 2016 6:58 AM Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial ResultsMay 31, 2016 6:46 AM Stocks with Implied Volatility MovementMay 31, 2016 6:15 AM